Dergiler / Journal of critical and intensive care (Online) / 2021 / Cilt: 12 - Sayı: 3

Efficiencies of Laboratory Parameters in Covid-19 Patients Follow up

Sayfa
91–95
Yayın Tarihi
2022-10-19
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Age, NLR, D-dimer, and CRP may be considered as predictors of mortality in COVID-19 patients.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Introduction: Diagnostic efficiencies of laboratory parameters used in COVID-19 patients and their association with disease severity were evaluated.
📊
Temel Bulgular & Veri:Materials and Methods: Laboratory parameters of COVID-19 patients hospitalized in Dr.
💡
Sonuç & Katkı:Age, NLR, D-dimer, and CRP may be considered as predictors of mortality in COVID-19 patients.
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:2020 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Introduction: Diagnostic efficiencies of laboratory parameters used in COVID-19 patients and their association with disease severity were evaluated. Materials and Methods: Laboratory parameters of COVID-19 patients hospitalized in Dr. Lütfi Kırdar Kartal City Hospital between March and August 2020 were evaluated. The patients were grouped as non-severe and severe according to the interim guidance of the World Health Organization (WHO). The diagnostic performances of NLR, D-dimer, CRP, procalcitonin, IL-6, LDH, and ferritin in discrimination of severe cases were evaluated by Receiver operator’s characteristics (ROC) analysis. Generalized lineer model Analysis (GLM) was performed with mortality as a dependent variable and age, gender, NLR, D-dimer, CRP, Procalcitonin, IL-6, LDH, and ferritin as an independent variables. Results: A total of 257 patients were evaluated and there was a significant difference between non-severe and severe cases in terms of NLR, D-dimer, CRP, Procalcitonin, IL-6, LDH, and Ferritin values. All the parameters showed comparable performances in discriminating severe disease; D-dimer with the least (AUC 73.5%), and NLR with the highest (AUC 80.7%) efficiency. Values above 4.5 for NLR, 930 ug/L for D-dimer, 64 mg/L for CRP, 0.136 ug/L for procalcitonin, 44.3 pg/mL for IL-6, 304 IU for LDH, and 312 ug/L for ferritin were associated with severe disease. Contribution of age, NLR, D-dimer, and CRP were found significant on the model. Conclusions: NLR, D-dimer, CRP, procalcitonin, IL-6, LDH, and ferritin showed comparable performances in discriminating severe cases with predefined cut-offs. Age, NLR, D-dimer, and CRP may be considered as predictors of mortality in COVID-19 patients.

🔖

Bu Makaleye Atıf Yap

ORCUN, A., MADENCİ, Ö. Ç., BATIREL, A., SARAÇOĞLU, K. T., YILDIZ, Z., ÖNEM1, İ. (2022). Efficiencies of Laboratory Parameters in Covid-19 Patients Follow up. Journal of critical and intensive care (Online), Cilt: 12 - Sayı: 3, 91–95. https://ajindex.com/articles/562284

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (2)

  1. WHO-China Joint Mission, Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19), (2020). https://www. who.int/publications/i/item/report-of-the-who-china-joint-missionon- coronavirus-disease-2019-(covid-19
  2. Pandemic C-19 C. No Title [Internet). Available from: https://www. worldometers.info/coronavirus/ 3. Mattiuzzi C, Lippi G. Which lessons shall we learn from the 2019 novel coronavirus outbreak? Ann Transl Med 2020;8:48. [CrossRef] 4. Ferrari D, Motta A, Strollo M, et. al. Routine blood tests as a potential diagnostic tool for COVID-19. Clin Chem Lab Med 2020;58:1095– 9. [CrossRef] 5. Wang R, Hozumi Y, Yin C, et al. Mutations on COVID-19 diagnostic targets. Genomics 2020;112:5204–13. [CrossRef] 6. Henry BM, de Oliveira MHS, Benoit S, et al. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019(COVID-19): a meta-analysis. Clin Chem Lab Med 2020;58:1021–8. [CrossRef] 7. Pourbagheri-Sigaroodi A, Bashash D, Fateh F, et al. Laboratory findings in COVID-19 diagnosis and prognosis. Clin Chim Acta 2020;510:475–82. [CrossRef] 8. Wang T, Du Z, Zhu F, et al. Comorbidities and multi-organ injuries in the treatment of COVID-19. Lancet 2020;395(10228):e52. [CrossRef] 9. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497–506. [CrossRef] 10. Liu Y, Yang Y, Zhang C, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci 2020;63:364–74. [CrossRef] 11. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395:507–13. [CrossRef] 12. Chang D, Lin M, Wei L, et al. Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, China. JAMA 2020;323:1092–1093. [CrossRef] 13. Tang N, Li D, Wang X, et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 2020;18:844–7. [CrossRef] 14. Thachil J, Tang N, Gando S, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost 2020;18:1023–6. [CrossRef] 15. World Health Organization. Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. https://www. who.int/p